Form 4 for SRPT Sarepta Therapeutics, Inc.
Accepted 2025-09-05 00:00:00 ET · period of report 2025-09-03 · accession 0001193125-25-197425 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-09-05 | 2025-09-03 | SRPT | Rodino-Klapac Louise | Pres, R, D, Tech Ops | A - Grant | $0.00 | +143.9K | 228.6K | +170% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-03 | A | A | 93,875 | $0.00 | 178,612 | D | — | — | (F1) The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. 50% of the RSUs will vest on September 3, 2026, and the remaining 50% will vest on September 3, 2027, subject to the Reporting Person's continued service to the Company. (F2) Includes 106 shares of common stock purchased on August 31, 2025 through the Company's Employee Stock Purchase Plan |
| 2 | Common | Common Stock | 2025-09-03 | A | A | 50,000 | $0.00 | 228,612 | D | — | — | (F3) The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. 100% of the RSUs will vest on September 3, 2028, subject to the Reporting Person's continued service to the Company and only if certain performance criteria has been deemed achieved by the Compensation Committee of the Board. |